Internal Medicine, Hematology & Oncology · Littleton, CO
NPI
1265675433
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
22 W Dry Creek Cir
Littleton, CO, 80120
Phone (303) 730-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.7M
188,825 services
Medicare patients, 2024
895
Average age 74
Drug cost, 2024
$7.5M
4,509 prescriptions
Company payments, 2025
$30K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manojkumar Bupathi was code J9271 (injection, pembrolizumab, 1 mg), 28,800 times for 34 patients. In total Manojkumar Bupathi billed 188,825 services in 200 codes, and Medicare paid $3.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 28,800 | 34 | $43.45 | $1.3M |
| J1453 Injection, fosaprepitant, 1 mg | Office | 11,250 | 30 | $0.11 | $1,267 |
| J1756 Injection, iron sucrose, 1 mg | Office | 7,000 | 20 | $0.17 | $1,212 |
| J9171 Injection, docetaxel, 1 mg | Office | 6,888 | 14 | $0.66 | $4,548 |
| J0897 Injection, denosumab, 1 mg | Office | 4,620 | 42 | $20.54 | $95K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 4,490 | 17 | $35.96 | $161K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,860 | 36 | $0.10 | $288 |
| 85025 Blood Count | Office | 2,221 | 544 | $7.58 | $17K |
| 36415 Venipuncture Blood Collection | Office | 2,115 | 555 | $8.64 | $18K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,055 | 61 | $0.09 | $184 |
| 80053 Clinical Chemistry | Office | 2,003 | 520 | $10.31 | $21K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,000 | 17 | $16.03 | $32K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,560 | 41 | $0.25 | $388 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,421 | 42 | $0.73 | $1,041 |
| J9395 Injection, fulvestrant, 25 mg | Office | 1,160 | 11 | $6.39 | $7,416 |
By year: 2022 $2.5M for 168,069 services; 2023 $2.5M for 120,552 services; 2024 $3.7M for 188,825 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,221 | 544 | $7.58 | $17K |
| 36415 Venipuncture Blood Collection | 2,115 | 555 | $8.64 | $18K |
| 80053 Clinical Chemistry | 2,003 | 520 | $10.31 | $21K |
| 82378 Clinical Chemistry | 722 | 287 | $18.41 | $13K |
| 86300 Immunoassay | 699 | 280 | $20.22 | $14K |
| 84153 Clinical Chemistry | 471 | 126 | $18.02 | $8,487 |
| 83735 Clinical Chemistry | 315 | 70 | $6.57 | $2,070 |
| 84443 Clinical Chemistry | 284 | 73 | $16.46 | $4,675 |
| 83615 Clinical Chemistry | 140 | 43 | $5.92 | $829 |
| 82728 Clinical Chemistry | 80 | 50 | $13.36 | $1,069 |
Medicare prescription drug claims, 2024
In 2024, the drug Manojkumar Bupathi prescribed most often to Medicare patients was Letrozole, with 831 prescriptions and refills. In total Manojkumar Bupathi wrote 4,509 Medicare prescriptions that cost $7.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 831 | 1,859 | 199 | $19K |
| Anastrozole Generic | 247 | 607 | 75 | $5,108 |
| Tamoxifen Citrate Generic | 218 | 512 | 57 | $4,243 |
| Prednisone Generic | 201 | 229 | 72 | $859 |
| Gabapentin Generic | 200 | 252 | 45 | $1,619 |
| Levothyroxine Sodium Generic | 192 | 371 | 51 | $3,311 |
| Alendronate Sodium Generic | 154 | 353 | 40 | $1,565 |
| Eliquis Apixaban | 119 | 177 | 25 | $99K |
| Duloxetine Hcl Generic | 99 | 186 | 24 | $1,709 |
| Erleada Apalutamide | 98 | 100 | 16 | $1.2M |
| Ondansetron Odt Ondansetron | 87 | 87 | 52 | $1,141 |
| Trazodone Hcl Generic | 81 | 133 | 25 | $496 |
| Abiraterone Acetate Generic | 80 | 89 | 15 | $35K |
| Cabometyx Cabozantinib S-Malate | 74 | 74 | 19 | $1.6M |
| Pregabalin Generic | 71 | 78 | 20 | $1,515 |
Brand drugs: - claims; generic drugs: 3,661 claims; opioid claims: 146.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manojkumar Bupathi $30K ($30K in general payments such as food, travel and fees) from 26 companies. The largest payer was Astellas Pharma Global Development with $6,434.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma Global Development 4503.T | 9 | $6,434 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $5,120 |
| Genentech USA, Inc. ROG.SW | 5 | $3,348 |
| Janssen Biotech, Inc. JNJ | 1 | $2,820 |
| EMD Serono, Inc. MRK.DE | 1 | $2,760 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $2,566 |
| Exelixis Inc. EXEL | 5 | $2,409 |
| Merck Sharp & Dohme LLC MRK | 4 | $2,305 |
| Daiichi Sankyo Inc. 4568.T | 1 | $1,471 |
| Gilead Sciences, Inc. GILD | 3 | $766 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.